YOLFTbeta
Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated

CORT · NASDAQ · Healthcare / Biotechnology

72.94USD-0.77 (-1.04%)

Price History

Full chart

Market Stats

Previous Close73.71
Open73.87
Day Range71.18 – 74.68
52-Week Range28.66 – 126.38
Volume1.11M
Market Cap8.77B
P/E (TTM)180.27
Forward P/E14.39
EPS0.45
Dividend Yield0.00%
Beta0.40
50-Day Avg111.98
200-Day Avg74.77

About

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. It also develops relacorilant, a selective cortisol modulator for patients with hypercortisolism; a selective cortisol modulator miricorilant, which is in Phase 1b trial for metabolic dysfunction-associated steatohepatitis; and a portfolio of proprietary selective cortisol modulators, such as relacorilant, nenocorilant, miricorilant, and dazucorilant for the treatment of Lou Gehrig's disease. The company was incorporated in 1998 and is headquartered in Redwood City, California.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Joseph K. Belanoff M.D.
  • Employees730
  • Headquarters101 Redwood Shores Parkway, Redwood City, CA, United States, 94065, USA
  • Websitehttps://www.corcept.com

Leadership

  • Dr. Joseph K. Belanoff M.D.Co-Founder, President, CEO & Director · b. 1957
  • Mr. Atabak MokariCFO & Treasurer · b. 1977
  • Dr. William Guyer Pharm.D.Chief Development Officer · b. 1968
  • Mr. Gary Charles Robb J.D.Chief Business Officer & Secretary · b. 1963
  • Mr. Joseph Douglas LyonChief Technology & Accounting Officer · b. 1978
  • Dr. Hazel Hunt Ph.D.Chief Scientific Officer · b. 1960
  • Ms. Amy FloodChief Human Resources & Communications Officer
  • Ms. Monica TelladoPresident of Emerging Markets · b. 1973
  • Mr. Roberto W. VieiraPresident of Oncology
  • Mr. Justin Gunn M.D.President of Endocrinology

Financials

Income Statement

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue------294.00K482.00K209.00K29.00K-03.31M10.36M26.55M50.29M81.32M159.20M251.25M306.49M353.87M365.98M401.86M482.38M675.04M761.41M
Growth (%)-------+63.95%-56.64%-86.12%---+213.18%+156.36%+89.39%+61.72%+95.77%+57.82%+21.99%+15.46%+3.42%+9.80%+20.04%+39.94%+12.79%
Cost of Revenue------25.86M12.71M19.89M20.27M-091.00K143.00K882.00K1.36M2.06M3.55M5.21M5.50M5.58M5.28M5.38M6.48M10.88M12.98M
Gross Profit------294.00K482.00K209.00K29.00K-03.22M10.21M25.67M48.92M79.26M155.65M246.03M300.98M348.29M360.70M396.47M475.89M664.16M748.43M
Gross Margin------100.00%100.00%100.00%100.00%--97.25%98.62%96.68%97.29%97.47%97.77%97.92%98.20%98.42%98.56%98.66%98.66%98.39%98.30%
Operating Expense------25.88M12.73M19.90M20.28M-32.33M39.49M51.71M53.29M52.37M69.08M102.79M156.54M189.38M220.09M236.22M283.84M368.61M527.21M703.63M
Operating Income--8.01M-18.80M-9.99M-16.04M-21.16M-25.58M-12.24M-19.69M-20.25M-27.44M-32.33M-36.27M-41.50M-27.62M-3.44M10.18M52.85M89.50M111.61M128.20M124.48M112.63M107.28M136.95M44.80M
Operating Margin-------8701.36%-2540.46%-9420.57%-69827.59%---1096.82%-400.66%-104.02%-6.85%12.52%33.20%35.62%36.41%36.23%34.01%28.03%22.24%20.29%5.88%
EBITDA--8.01M-18.80M-9.97M-15.47M-20.09M-25.58M-12.24M-19.69M-20.25M-25.96M-32.35M-36.24M-41.42M-27.48M-3.29M10.27M52.96M89.73M113.78M130.44M127.54M115.60M126.92M162.83M68.35M
EBITDA Margin-------8701.36%-2540.46%-9420.57%-69827.59%---1096.01%-399.94%-103.49%-6.54%12.62%33.27%35.71%37.12%36.86%34.85%28.77%26.31%24.12%8.98%
Net Income--7.45M-18.50M-9.81M-15.53M-20.09M-24.87M-11.57M-20.06M-20.17M-25.97M-32.35M-38.05M-46.01M-31.38M-6.41M8.14M129.12M75.41M94.18M106.01M112.51M101.42M106.14M139.73M99.65M
Net Income Margin-------8460.20%-2401.04%-9598.56%-69537.93%---1150.53%-444.25%-118.20%-12.74%10.01%81.11%30.01%30.73%29.96%30.74%25.24%22.00%20.70%13.09%
R&D1.32M5.39M13.26M8.11M11.55M17.07M20.83M7.86M14.15M14.40M18.95M21.00M14.07M20.47M18.37M15.42M23.84M40.38M75.25M89.02M114.76M113.86M130.99M184.35M246.89M254.91M
R&D as % of Total Revenue------7086.39%1630.71%6771.29%49662.07%--425.58%197.64%69.20%30.66%29.32%25.36%29.95%29.04%32.43%31.11%32.60%38.22%36.57%33.48%
Interest Expense00000000944.00K101.00K1.50M3.00K1.78M4.51M3.76M2.96M2.04M49.00K2.66M5.07M5.64M3.60M3.56M---
Interest Expense % of Total Revenue------0.00%0.00%451.67%348.28%--53.70%43.59%14.18%5.90%2.51%0.03%1.06%1.65%1.59%0.98%0.89%---

Balance Sheet

Currency: USD2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.05M24.26M21.80M11.78M47.77M30.16M9.90M17.74M19.77M24.51M25.10M39.83M99.17M63.08M34.63M51.94M68.75M220.54M311.69M412.31M571.73M423.76M583.43M621.52M840.55M836.65M
Total Liabilities1.24M1.88M43.73M1.54M1.82M3.56M3.54M3.01M2.87M2.42M3.86M5.03M37.39M42.06M38.02M33.44M27.37M29.57M35.81M41.13M48.39M47.95M81.59M114.81M160.96M188.85M
Total Equity-196.00K22.38M-21.94M10.24M45.95M26.59M6.36M14.73M16.91M22.09M21.24M34.81M61.78M21.02M-3.39M18.50M41.38M190.97M275.88M371.18M523.34M375.81M501.84M506.70M679.59M647.80M
Cash1.00M-18.40M10.07M5.93M3.82M8.91M11.43M14.72M23.87M24.58M39.63M93.03M54.88M24.25M40.44M51.54M104.03M206.76M31.27M476.89M77.62M66.33M135.55M127.67M120.50M
Total Debt---523.69K-54.00K42.00K29.00K16.00K6.00K--31.68M35.06M33.89M27.53M14.66M--3.46M2.55M526.00K1.14M151.00K6.94M6.11M
Net Debt----9.55M-5.93M-3.76M-8.86M-11.40M-14.70M-23.86M-24.58M-39.63M-90.38M-49.13M-14.82M-25.47M-36.87M-104.03M-206.76M-27.81M-474.34M-77.09M-65.19M-135.40M-120.73M-114.39M

Cash Flow

Currency: USD2000-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---10.00M-13.72M-17.23M-23.24M-10.96M-18.36M-17.97M-22.29M-27.40M-36.02M-37.06M-27.38M3.13M18.39M60.94M115.67M136.12M151.97M167.89M120.32M127.04M198.07M142.00M
Investing Cash Flow--1.64M-39.51M15.11M25.36M-5.38M2.33M3.59M--25.00K-151.00K-127.00K-174.00K-17.00K-194.00K-73.46M-90.77M-117.83M-119.26M136.13M-114.33M90.91M-177.60M69.76M
Financing Cash Flow2.08M11.80M37.57K49.09M12.00K2.97M18.87M19.32M23.52M23.00M42.48M89.57M-970.00K-3.08M13.07M-7.10M-7.95M-14.34M-28.64M12.21M-302.59M-17.28M-148.72M-28.35M-220.37M
Capital Expenditure28.00K7.00K0103.90M25.86M1.31M07.00K7.00K025.00K151.00K127.00K174.00K17.00K194.00K419.00K298.00K1.09M1.24M469.00K413.00K139.00K2.17M211.00K
Free Cash Flow---10.00M-117.62M-43.10M-24.55M-10.96M-18.37M-17.98M-22.29M-27.43M-36.17M-37.19M-27.55M3.11M18.20M60.52M115.37M135.03M150.73M167.42M119.91M126.90M195.90M141.78M
Dividends Paid----------0000000-6.97M21.54M14.20M23.86M---
FCF to OCF--100.00%857.39%250.07%105.66%100.00%100.04%100.04%100.00%100.09%100.42%100.34%100.64%99.46%98.95%99.31%99.74%99.20%99.19%99.72%99.66%99.89%98.90%99.85%
Dividend Paid to FCF----------0.00%0.00%0.00%0.00%0.00%0.00%0.00%-5.16%14.29%8.48%19.90%---

Earnings

Report DateMay 26, 2004Aug 9, 2004Oct 28, 2004Mar 3, 2005May 11, 2005Aug 9, 2005Nov 8, 2005Mar 8, 2006May 9, 2006Aug 10, 2006Nov 8, 2006Mar 28, 2007May 9, 2007Aug 13, 2007Nov 8, 2007Mar 27, 2008May 12, 2008Aug 13, 2008Nov 13, 2008Mar 30, 2009May 11, 2009Aug 11, 2009Nov 10, 2009Mar 25, 2010May 11, 2010Aug 12, 2010Nov 10, 2010Mar 9, 2011May 4, 2011Aug 8, 2011Nov 7, 2011Mar 5, 2012May 3, 2012Aug 7, 2012Oct 31, 2012Mar 7, 2013May 2, 2013Aug 8, 2013Nov 7, 2013Mar 5, 2014May 7, 2014Aug 5, 2014Nov 4, 2014Mar 4, 2015May 7, 2015Aug 5, 2015Nov 5, 2015Mar 1, 2016May 3, 2016Aug 2, 2016Nov 1, 2016Jan 30, 2017May 1, 2017Aug 1, 2017Nov 2, 2017Feb 22, 2018May 8, 2018Aug 9, 2018Nov 1, 2018Feb 25, 2019May 9, 2019Aug 1, 2019Nov 7, 2019Feb 20, 2020May 4, 2020Aug 4, 2020Nov 3, 2020Feb 8, 2021May 6, 2021Jul 29, 2021Nov 3, 2021Feb 15, 2022May 5, 2022Aug 3, 2022Nov 3, 2022Feb 28, 2023May 3, 2023Aug 2, 2023Nov 1, 2023Feb 15, 2024May 1, 2024Jul 29, 2024Oct 30, 2024Feb 13, 2025May 5, 2025Jul 31, 2025Nov 4, 2025Feb 18, 2026Apr 30, 2026Jul 29, 2026Nov 3, 2026
EPS Estimate--0.19-0.25-0.29-0.28-0.30-0.24-0.25-0.26-0.27-0.28-0.28-0.18-0.09-0.10-0.10-0.15-0.10-0.11-0.11-0.09-0.11-0.10-0.10-0.08-0.09-0.10-0.10-0.10-0.09-0.11-0.09-0.11-0.12-0.09-0.09-0.10-0.11-0.12-0.10-0.09-0.10-0.07-0.07-0.04-0.04-0.02-0.010.010.020.010.020.030.070.140.180.180.240.210.150.180.190.210.260.220.210.230.170.190.170.210.350.310.280.280.230.210.150.230.260.220.240.290.420.140.190.140.25-0.14-0.040.68
EPS Actual-0.28-0.18-0.18-0.24-0.24-0.18-0.23-0.23-0.30-0.35-0.28-0.16-0.10-0.04-0.09-0.11-0.10-0.09-0.11-0.13-0.11-0.10-0.09-0.09-0.10-0.09-0.10-0.10-0.09-0.11-0.08-0.12-0.13-0.09-0.08-0.11-0.10-0.10-0.08-0.09-0.14-0.07-0.06-0.02-0.05-0.02-0.010.01-0.000.010.020.040.040.100.140.170.190.200.220.180.200.250.310.330.250.320.240.270.200.300.240.350.200.240.300.140.140.250.280.280.250.320.410.260.170.290.160.20-0.300.36-
Surprise-5.26%28.00%17.24%14.29%40.00%4.17%8.00%-15.38%-29.63%0.00%42.86%44.44%55.56%10.00%-10.00%33.33%10.00%0.00%-18.18%-22.22%9.09%10.00%10.00%-25.00%0.00%0.00%0.00%10.00%-22.22%27.27%-33.33%-18.18%25.00%11.11%-22.22%0.00%9.09%33.33%10.00%-55.56%30.00%14.29%71.43%-25.00%50.00%50.00%200.00%-102.00%-50.00%100.00%100.00%33.33%42.86%0.00%-5.56%5.56%-16.67%4.76%20.00%11.11%31.58%47.62%26.92%13.64%52.38%4.35%58.82%5.26%76.47%14.29%0.00%-35.48%-14.29%7.14%-39.13%-33.33%66.67%21.74%7.69%13.64%33.33%41.38%-38.58%21.43%52.63%14.29%-21.26%-114.29%1000.00%-
Timing-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursPre-market-Pre-marketAfter-hoursPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap8.77B
Enterprise Value8.47B
Trailing P/E180.27
Forward P/E14.39
PEG Ratio0.81
Price / Sales10.55
Price / Book12.42
EPS0.45
Book Value6.54
Revenue (TTM)830.81M
Gross Profit (TTM)816.73M
EBITDA8.08M
Profit Margin6.64%
Operating Margin16.12%
Return on Equity8.23%
Return on Assets0.47%
Shares Outstanding108.10M
Shares Float96.49M
Beta0.40
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 5 analystsTarget 141.00
  • Strong Buy
    3
  • Buy
    1
  • Strong Sell
    1

Ownership Breakdown

Institutions
76.99%
Insiders
11.46%
Retail / Other
11.55%

Top Institutional Holders

  • BlackRock Inc
    12.43M11.50%
  • Ingalls & Snyder LLC
    7.93M7.34%
  • Renaissance Technologies Corp
    5.26M4.87%
  • Vanguard Portfolio Management, LLC
    5.04M4.67%
  • Vanguard Capital Management, LLC
    4.17M3.86%
  • Parallel Advisors, LLC
    3.96M3.67%
  • FMR Inc
    3.34M3.09%
  • State Street Corp
    3.28M3.03%
  • AQR Capital Management LLC
    2.58M2.39%
  • Geode Capital Management, LLC
    2.53M2.34%
  • First Trust Advisors L.P.
    1.83M1.69%
  • TANG CAPITAL MANAGEMENT LLC
    1.50M1.39%
  • UBS Group AG
    1.38M1.27%
  • Dimensional Fund Advisors, Inc.
    1.32M1.22%
  • Charles Schwab Investment Management Inc
    1.16M1.07%

Top Fund Holders

  • iShares Core S&P Mid-Cap ETF
    3.42M3.16%
  • Vanguard MStar Total Stk Mkt Idx Invest
    3.09M2.86%
  • Vanguard Small Cap Index
    2.19M2.03%
  • Fidelity Contrafund
    1.46M1.35%
  • Vanguard MStar Small Cap Growth Indx Inv
    1.22M1.13%